Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics
Résumé
SARS-CoV-2 mRNA vaccination generates protective B cell responses targeting the SARS-CoV-2 spike glycoprotein. Whereas anti-spike memory B cell responses are long-lasting, the anti-spike humoral antibody response progressively wanes, making booster vaccinations necessary for maintaining protective immunity. Here we investigated qualitatively the plasmablast responses by measuring from single cells within hours of sampling the affinity of their secreted antibody for the SARS-CoV-2 spike receptor binding domain in cohorts of BNT162b2-vaccinated naive and COVID-19-recovered individuals. Using a unique droplet microfluidic and imaging approach, we analyzed >4,000 single IgG-secreting cells revealing high inter-individual variability in affinity for RBD with variations over 4 logs. High-affinity plasmablasts were induced by BNT162b2 vaccination against Hu-1 and Omicron RBD but disappeared quickly thereafter, whereas low-affinity plasmablasts represented >65% of the plasmablast response at all timepoints. Our droplet-based method thus proves efficient at fast and qualitative immune monitoring and should be helpful for optimization of vaccination protocols.
Fichier principal
166602.1-20230530091711-covered-e0fd13ba177f913fd3156f593ead4cfd.pdf (6.97 Mo)
Télécharger le fichier
166602-INS-TA-RV-3_sd_678794.pdf (28.58 Mo)
Télécharger le fichier
166602-INS-TA-RV-3_sd_678796.xlsx (19.1 Ko)
Télécharger le fichier
